Govt panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster dose
India TodayAn expert panel of India’s central drug authority has recommended permission to conduct a phase-3 clinical trial of the single-dose Covid-19 vaccine ‘Sputnik Light’ as a booster dose, official sources said on Saturday. "The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation, which reviewed the application on Friday after detailed deliberation, recommended granting permission for the phase-3 clinical trial with condition to initiate the trial with Sputnik Light vaccine for which the firm is holding emergency use authorisation permission in the country subject to certain regulatory provisions," an official source said. READ | Decision on mixing and matching of booster dose of Covid vaccines will be based on science: Govt The DCGI had on February 4 granted emergency use permission for the Sputnik Light vaccine in India, subject to certain regulatory provisions. Hyderabad-based Dr Reddy’s Laboratories had proposed to DCGI to conduct a phase-3 trial of the Sputnik Light vaccine as a booster dose.